tiprankstipranks
Trending News
More News >

Daito Pharmaceutical Announces Share Repurchase

Story Highlights
Daito Pharmaceutical Announces Share Repurchase

Confident Investing Starts Here:

The latest update is out from Daito Pharmaceutical Co., Ltd. ( (JP:4577) ).

Daito Pharmaceutical Co., Ltd. announced the repurchase of 105,200 of its own shares for 220,726,800 yen, conducted through market purchases on the Tokyo Stock Exchange in April 2025. This move is part of a broader strategy approved by the Board of Directors to repurchase up to 300,000 shares, aiming to enhance shareholder value and optimize capital structure.

More about Daito Pharmaceutical Co., Ltd.

Daito Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is listed on the Prime Market of the Tokyo Stock Exchange.

YTD Price Performance: -2.39%

Average Trading Volume: 31,975

Technical Sentiment Signal: Buy

Current Market Cap: Yen31.3B

See more insights into 4577 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App